Literature DB >> 28729112

No. 208-Guidelines for the Management of Herpes Simplex Virus in Pregnancy.

Deborah M Money1, Marc Steben2.   

Abstract

OBJECTIVE: To provide recommendations for the management of genital herpes infection in women who want to get pregnant or are pregnant and for the management of genital herpes in pregnancy and strategies to prevent transmission to the infant. OUTCOMES: More effective management of complications of genital herpes in pregnancy and prevention of transmission of genital herpes from mother to infant. EVIDENCE: Medline was searched for articles published in French or English related to genital herpes and pregnancy. Additional articles were identified through the references of these articles. All study types and recommendation reports were reviewed. VALUES: Recommendations were made according to the guidelines developed by the Canadian Task Force on Preventive Health Care. RECOMMENDATIONS: VALIDATION: These guidelines have been reviewed and approved by the Infectious Diseases Committee of the SOGC. SPONSOR: The Society of Obstetricians and Gynaecologists of Canada.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  HSV; antiviral; counselling; genital herpes; pregnancy; prevention; screening

Mesh:

Substances:

Year:  2017        PMID: 28729112     DOI: 10.1016/j.jogc.2017.04.016

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  2 in total

1.  Development of a community-based hearing loss prevention and control service model in Guangdong, China.

Authors:  Chang Liu; Anshi Wang; Yanlin Huang; Yan Zhang; Hongke Ding; Jing Wu; Li Du; Jie Yang; Fei Mai; Yukun Zeng; Ling Liu; Xin Zhao; Changbin Zhang; Aihua Yin
Journal:  BMC Public Health       Date:  2019-11-29       Impact factor: 3.295

2.  Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse Model.

Authors:  Allison M Felker; Philip Nguyen; Charu Kaushic
Journal:  Viruses       Date:  2021-09-25       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.